NCT03768349View on ClinicalTrials.gov

PSMA and C-11 Choline PET in Patients With Biochemical Recurrence of Prostate Cancer

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

January 3, 2019

Primary Completion Date

July 21, 2021

Study Completion Date

July 21, 2021

Conditions
Prostate Cancer
Interventions
DRUG

Ga-68 PSMA11

Ga-68 PSMA11 PET/CT for detection of tumor location

DRUG

F-18 PSMA 1007

F-18 PSMA 1007 PET/CT for detection of tumor location

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT03768349 - PSMA and C-11 Choline PET in Patients With Biochemical Recurrence of Prostate Cancer | Biotech Hunter | Biotech Hunter